Volume 68 Received 29 October 2012 | ||||||||||
| ||||||||||
aChemistry Department, "Sapienza" University of Rome, P.le A. Moro, 5, I-00185 Rome, Italy
Correspondence e-mail: g.portalone@caspur.it
The title compound, C8H11N2O+·CH3CO2-, was synthesized by a reaction between 4-methoxybenzamidine (4-amidinoanisole) and acetic acid. In the cation, the amidinium group forms a dihedral angle of 11.65 (17)° with the mean plane of the benzene ring. The ionic components are associated in the crystal via N-H+
O- hydrogen bonds, resulting in a one-dimensional structure consisting of dimers and catemers and orientated approximately along the c axis.
For the biological and pharmacological relevance of benzamidine, see: Powers & Harper (1999
). For structural analysis of proton-transfer adducts containing molecules of biological interest, see: Portalone, (2011a
); Portalone & Irrera (2011
). For the supramolecular association in proton-transfer adducts containing benzamidinium cations, see; Portalone (2010
, 2011b
, 2012
); Irrera & Portalone (2012a
,b
); Irrera et al. (2012
). For hydrogen-bond motifs, see Bernstein et al. (1995
). For standard bond lengths, see: Allen et al. (1987
).
|
|
|
Data collection: CrysAlis PRO (Agilent, 2011
); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SIR97 (Altomare et al., 1999
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 (Farrugia, 1997
); software used to prepare material for publication: WinGX (Farrugia, 1999
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: TK5166 ).
Agilent (2011). CrysAlis PRO. Agilent Technologies, Yarnton, England.
Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Altomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115-119.
![[details]](../../../../../../j/graphics/details.gif)
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.
![[ISI]](../../../../../../logos/isiborder.gif)
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
![[details]](../../../../../../j/graphics/details.gif)
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.
![[details]](../../../../../../j/graphics/details.gif)
Irrera, S., Ortaggi, G. & Portalone, G. (2012). Acta Cryst. C68, o447-o451.
![[details]](../../../../../../c/graphics/details.gif)
Irrera, S. & Portalone, G. (2012a). Acta Cryst. E68, o3083.
![[details]](../../../../../../e/graphics/details.gif)
Irrera, S. & Portalone, G. (2012b). Acta Cryst. E68, o3244.
![[details]](../../../../../../e/graphics/details.gif)
Portalone, G. (2010). Acta Cryst. C66, o295-o301.
![[details]](../../../../../../c/graphics/details.gif)
Portalone, G. (2011a). Chem. Centr. J. 5, 51.
![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Portalone, G. (2011b). Acta Cryst. E67, o3394-o3395.
![[details]](../../../../../../e/graphics/details.gif)
Portalone, G. (2012). Acta Cryst. E68, o268-o269.
![[details]](../../../../../../e/graphics/details.gif)
Portalone, G. & Irrera, S. (2011). J. Mol. Struct. 991, 92-96.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Powers, J. C. & Harper, J. W. (1999). Proteinase inhibitors, edited by A. J. Barrett & G. Salvesen, pp. 55-152. Elsevier: Amsterdam.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)